Janus kinase 2 (JAK2) inhibitors in the treatment of multiple myeloma: modulating the myeloma immune microenvironment

被引：4
|
作者：
Giles, Hannah [1 ]
Pratt, Guy [1 ]
机构：
[1] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 192卷 / 03期
关键词：
JAK2; inhibitors; multiple myeloma; myeloma immune; microenvironment; FUNCTION IN-VITRO; CELL-FUNCTION; RUXOLITINIB; TOFACITINIB; EFFICACY; DISEASE;
D O I：
10.1111/bjh.17277
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：420 / 422
页数：3
相关论文
共 50 条
  • [31] THROMBOPOIETIN INDUCES TYROSINE PHOSPHORYLATION AND ACTIVATION OF THE JANUS KINASE, JAK2
    TORTOLANI, PJ
    JOHNSTON, JA
    BACON, CM
    MCVICAR, DW
    SHIMOSAKA, A
    LINNEKIN, D
    LONGO, DL
    OSHEA, JJ
    BLOOD, 1995, 85 (12) : 3444 - 3451
  • [32] TYROSINE-PROTEIN KINASE JAK2 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Majumder, A.
    Sayeski, P. P.
    DRUGS OF THE FUTURE, 2010, 35 (08) : 651 - 660
  • [33] JAK2 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Tefferi, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 20 - 21
  • [34] JAK2 inhibitors in the treatment of myeloproliferative neoplasms
    Tibes, Raoul
    Bogenberger, James M.
    Geyer, Holly L.
    Mesa, Ruben A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1755 - 1774
  • [35] The impact of binding site waters on the activity/selectivity trade-off of Janus kinase 2 (JAK2) inhibitors
    Egyed, Attila
    Bajusz, David
    Keseru, Gyorgy M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (08) : 1497 - 1508
  • [36] Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice
    Shi, Sally Yu
    Luk, Cynthia T.
    Schroer, Stephanie A.
    Kim, Min Jeong
    Dodington, David W.
    Sivasubramaniyam, Tharini
    Lin, Lauren
    Cai, Erica P.
    Lu, Shun-Yan
    Wagner, Kay-Uwe
    Bazinet, Richard P.
    Woo, Minna
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (09) : 3789 - 3799
  • [37] Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice
    Krempler, A
    Qi, YY
    Triplett, AA
    Zhu, JQ
    Rui, HH
    Wagner, KU
    GENESIS, 2004, 40 (01) : 52 - 57
  • [38] The discovery of 2,5-isomers of triazole-pyrrolopyrimidine as selective Janus kinase 2 (JAK2) inhibitors versus JAK1 and JAK3
    Lee, Sun-Mi
    Yoon, Kyoung Bin
    Lee, Hyo Jeong
    Kim, Jiwon
    Chung, You Kyoung
    Cho, Won-Jea
    Mukai, Chisato
    Choi, Sun
    Kang, Keon Wook
    Han, Sun-Young
    Ko, Hyojin
    Kim, Yong-Chul
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5036 - 5046
  • [39] 2,5-Isomers of triazole-pyrrolopyrimidine act as selective inhibitors of Janus kinase 2 (JAK2) compared to JAK1 and JAK3
    Sun-mi, Lee
    Kim, Yong-Chul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [40] Effect of small molecule inhibitors of JAK2 kinase on modulating signaling cascades downstream of cytokine receptors
    Olsen, Colin E.
    Gourley, Eric S.
    Liu, Xiao-Hui
    Walker, Jeff
    Grand, Cory L.
    Warner, Steven L.
    Vankayalapati, Hariprasad
    Bearss, David J.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3592S - 3592S
12345